TY - JOUR T1 - Resource requirements for reintroducing elective surgery in England during the COVID-19 pandemic: a modelling study JF - medRxiv DO - 10.1101/2020.06.10.20127266 SP - 2020.06.10.20127266 AU - A. J. Fowler AU - T. D. Dobbs AU - Y. I. Wan AU - R. Laloo AU - S. Hui AU - D. Nepogodiev AU - A. Bhangu AU - I. S. Whitaker AU - R. M. Pearse AU - T. E. F. Abbott Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/06/12/2020.06.10.20127266.abstract N2 - Background The response to COVID-19 has required cancellation of all but the most urgent surgeries, including many cancer operations. We estimated the number of cancelled surgical procedures in the National Health Service (NHS) in England due to COVID-19 and how this deficit would change over time once elective surgery was reintroduced.Methods Modelling study using Hospital Episode Statistics (HES) data from 2014 to 2019. Using NHS England definitions, surgical procedures were grouped into four classes of urgency. We calculated time-weighted average numbers of surgical procedures from 1st March 2020 and extrapolated to 28th February 2021 informed by activity in previous years. We estimated the procedure deficit using multiple conservative assumptions and then modelled the reintroduction of elective surgery between 1st June 2020 and 28th February 2021, estimating the resources required to achieve this. Costs of surgery were calculated using NHS reference costs. Estimates are reported with 95% confidence intervals.Findings 4,547,534 (3,318,195 - 6,250,771) patients with pooled mean age of 53.5 years were expected to undergo surgery in the NHS in England between 1st March 2020 and 28th February 2021. Due to COVID-19, 749,248 (513,565 - 1,077,448) surgical procedures were cancelled by 31st May 2020. As current guidelines require a gradual reintroduction of elective surgery, this deficit will increase further and 2,270,178 (1,453,057 - 3,363,472) patients will be awaiting surgery by 28th February 2021. The cost of these delayed procedures is £4,688,318,443 (£2,726,364,240 - £7,070,166,056). However, the safe delivery of surgery during the pandemic will require substantial extra resources including personal protective equipment and universal preoperative screening, leading to additional costs of £606,252,901 (£521,159,931 - £730,720,808).Interpretation Reintroduction of elective surgery during the pandemic response in NHS England will be associated with substantial treatment delays for many patients, and a large increase in treatment costs.Funding NIHR (DRF-2018-11-ST2-062) to AJF.Competing Interest StatementAJF reports a grant from the National Institute for Health Research (DRF-2018-11-ST2-062). TDD reports funding from the Welsh Clinical Academic Training (WCAT) Fellowship. IW reports active grants from the American Association of Plastic Surgeons and the European Association of Plastic Surgeons; is an editor for Frontiers of Surgery, associate editor for the Annals of Plastic Surgery, editorial board of BMC Medicine and numerous other editorial board roles. RP reports grants from NIHR, during the conduct of the study; grants and personal fees from Edwards Life Sciences, grants and non-financial support from Intersurgical UK, outside the submitted work; and has given lectures and/or performed consultancy work for Nestle Health Sciences, BBraun, Intersurgical, GlaxoSmithKline and Edwards Lifesciences, and holds editorial roles with the British Journal of Anaesthesia, the British Journal of Surgery and BMJ Quality and Safety. TA is a member of the associate editorial board of the British Journal of Anaesthesia. All other authors report no relationships or activities that could appear to have influenced the submitted work.Clinical TrialStudy using routinely collected, anonymised data only.Clinical Protocols https://qmro.qmul.ac.uk/xmlui/handle/123456789/64678 Funding StatementNIHR (DRF-2018-11-ST2-062) to AJFAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No ethical approval was required for this study that used pubicly available, aggregated, anonymised data.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data is freely available on the NHS Digital Website and the NHS England Website. The definition of surgery is available in the supplement of our publication. https://digital.nhs.uk/data-and-information/publications/statistical/hospital-admitted-patient-care-activity https://www.england.nhs.uk/statistics/statistical-work-areas/hospital-activity/monthly-hospital-activity/mar-data/ https://academic.oup.com/bja/article/119/2/249/4049141 ER -